Oct 21 (Reuters) - AstraZeneca said on Wednesday the US Food and Drug Administration granted accelerated approval for its ...

Awards recognize supply chain innovation, long-term partnership, and community engagement at OMP conferences in ...

AstraZeneca is teaming up with Oracle to refine clinical research, in the latest artificial-intelligence partnership in the ...

AstraZeneca and Oracle team up on AI, aiming to speed up clinical trials and improve patient care pathways, with the first ...

AstraZeneca has submitted applications in the U.S. and China seeking first-line use, with both regulators granting ...

Jefferies, the investment bank, estimates a 59% probability that AstraZeneca PLC (LSE:AZN, NYSE:AZN)’s zibotentan succeeds in ...

AstraZeneca stock rises 2.4% today to GBX12,928 while investors await the nine-month and Q3 2026 results update.

AstraZeneca said it received U.S. approval for its Ultomiris drug as a treatment for foamy urine in adults with immunoglobulin A nephropathy, a rare condition that can lead to chronic kidney disease.

AstraZeneca (NYSE: AZN), whose U.S. headquarters is in Wilmington, Delaware, and Oracle Health and Life Sciences announced on ...

Oct 20 () - AstraZeneca said on Tuesday that it is working with Oracle to ‌use AI and real-world data to identify ‌eligible patients for clinical trials and monitor safety signals, among ​other ...

Oct 20 () - Amgen and AstraZeneca said on Tuesday their asthma drug helped reduce swallowing difficulties and achieved ...

Oracle kicked off the year by launching its Oracle Life Sciences AI Data Platform, which it touted as using generative AI, ...